Stay updated on IONIS-FB-LRx in Primary IgA Nephropathy Clinical Trial
Sign up to get notified when there's something new on the IONIS-FB-LRx in Primary IgA Nephropathy Clinical Trial page.

Latest updates to the IONIS-FB-LRx in Primary IgA Nephropathy Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check23 days agoChange DetectedThe page has undergone significant content removal, particularly regarding a clinical study on IONIS-FB-LRx for primary IgA nephropathy, including detailed study design, inclusion and exclusion criteria, and previous version information. The only notable addition is the mention of 'Primary IgA Nephropathy' and a new revision number.SummaryDifference21%
- Check30 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to January 23, 2025.SummaryDifference0.6%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference2%
- Check88 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.SummaryDifference2%
- Check95 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.1%
Stay in the know with updates to IONIS-FB-LRx in Primary IgA Nephropathy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IONIS-FB-LRx in Primary IgA Nephropathy Clinical Trial page.